Presatovir (GS-5806) is an antiviral drug which was developed as a treatment for respiratory syncytial virus. It acts as a fusion inhibitor, and has shown...
4 KB (253 words) - 04:23, 25 March 2024
has shown good results in Phase II and III clinical trials. Palivizumab Presatovir Lumicitabine Zheng X, Gao L, Wang L, Liang C, Wang B, Liu Y, et al. (July...
3 KB (171 words) - 19:10, 25 January 2023
immunocompromised, such as those undergoing hematopoietic stem cell transplants. Presatovir, an experimental antiviral drug, has shown promising results in clinical...
98 KB (9,650 words) - 06:14, 25 November 2024
and it has been found to show activity against Nipah virus. Palivizumab Presatovir Ziresovir Wang G, Deval J, Hong J, Dyatkina N, Prhavc M, Taylor J, Fung...
4 KB (343 words) - 04:26, 25 March 2024
Mericitabine† Molnupiravir NITD008§ Ribavirin# Taribavirin† Triazavirin Valopicitabine† Multiple/Unknown/Other EICAR§ Merimepodib§ Moroxydine Presatovir†...
26 KB (2,541 words) - 07:34, 24 November 2024